IP Library › Granted Patent US 1,072,865
Granted Patent S1
US 1,072,865 · App. 29/916,052 · Granted Apr 29, 2025

Display screen or portion thereof with transitional graphical user interface

Inventors: Hideki Yamamoto (Kyoto, JP); Kosuke Uchiyama (Kyoto, JP)
Assignee: SHIMADZU CORPORATION
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 1,072,865
App. No.
29/916,052
Granted
Apr 29, 2025
Kind
S1
Claims (1)

The ornamental design for a display screen or portion thereof with transitional graphical user interface as shown and described.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2023
From: YAMAMOTO, HIDEKI; UCHIYAMA, KOSUKE
To: SHIMADZU CORPORATION
Reel/Frame 065518/0095 →
Priority Claims (1)
JP 2023-010991 D · May 31, 2023 · national
References Cited (16)
US D800743S · Rhodes · 2017 [cited by examiner]
US D875781S · Larsson · 2020 [cited by examiner]
US D884024S · Kwiatkowski · 2020 [cited by examiner]
US 10893067B1 · Geil · 2021 [cited by examiner]
US D916828S · Daie · 2021 [cited by examiner]
US D918263S · Park · 2021 [cited by examiner]
US D926202S · Connolly · 2021 [cited by examiner]
US D962259S · Trice · 2022 [cited by examiner]
US D965025S · Tikkanen · 2022 [cited by examiner]
US D970517S · Trice · 2022 [cited by examiner]
US D978879S · Crone · 2023 [cited by examiner]
US 20020147728A1 · Goodman · 2002 [cited by examiner]
US 20200174630A1 · Rosenberg · 2020 [cited by examiner]
CN 307563013 · 2022 [cited by examiner]
“A Critical N-Nitrosamine Impurity of Anticoagulant Drug” Jan. 13, 2022, www.link.springer.com, site visited: Feb. 18, 2025, https://link.springer.com/article/10.1007/s10337-021-04115-x (Year: 2022). [cited by examiner]
“Solutions for Nitrosamine Analysis”, Feb. 17, 2022, www.shimadzu.com, site visited Feb. 18, 2025: https://www.shimadzu.com/an/industries/small-molecule-pharmaceutical/development/analysis-of-nitrosamine-impurities-acco… [cited by examiner]